17.30EUR-0.35%Mkt Cap: 2.83B $P/E: 18.211d ago
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a g…
Industry Peers
Medical Instruments & Suppliesvs Medical Instruments & Supplies
P/E
Cheaper
P/B
Avg
Div Yield
Avg
1M Perf
Higher
Indicators:|
Key Statistics
Company
Market Cap2.83B $
Enterprise Value3.13B $
Revenue (TTM)1.08B $
Gross Profit361.37M $
Net Income (TTM)159.19M $
Revenue/Share7.188 USD
Last Price17.30 EUR
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees4.8K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE000A3ENQ51
Valuation
P/E (Trailing)18.21
P/E (Forward)16.34
PEG—
EV/EBITDA11.25
EV/Revenue2.91
P/S2.63
P/B2.77
EPS (TTM)0.95
EPS (Forward)1.06
52W Range
12.6228% of range29.50
52W High29.50 EUR
52W Low12.62 EUR
Profitability
Gross Margin33.71%
Oper. Margin15.95%
EBITDA Margin25.85%
Profit Margin14.85%
ROE16.42%
ROA9.16%
Growth
Revenue Growth-1.50%
Earnings Growth-16.00%
Cash Flow & Leverage
Operating CF195.57M $
CapEx (TTM)157.34M $
FCF Margin-3.30%
FCF Yield-1.25%
Net Debt297.86M $
Net Debt/EBITDA1.07
Balance Sheet
Debt/Equity0.09
Current Ratio1.59
Quick Ratio0.69
Book Value/Sh6.256 EUR
Cash/Share0.1850 EUR
Dividends
Fwd Div Rate0.1800 EUR
Trail. Div Rate0.1800 EUR
Div. Yield1.05%
5Y Avg Yield—
Payout Ratio18.95%
Ex-Div DateFeb 4, 2026
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.43 EUR
Upside (mean)+12.3%
Target Range13.00 EUR – 25.90 EUR
€13.00+12.3% to mean€25.90
# Analysts12
Ownership
Shares Out.150.61M
Float34.64M
Insiders77.00%
Institutions19.28%
Technical
SMA 5016.50 (+4.9%)
SMA 20016.38 (+5.6%)
Beta0.94
S&P 52W Chg20.05%
Avg Vol (30d)58.01K
Avg Vol (10d)37.96K
Technical Indicators
RSI (14)56.2
MACD0.1598
MACD Signal0.2172
MACD Hist.-0.0574
BB Upper17.85 EUR
BB Middle17.23 EUR
BB Lower16.62 EUR
BB Width7.17%
ATR (14)0.5848 EUR
Vol Ratio (20d)0.83x